Secondary acute myeloid leukemia (AML) is a blood cancer that arises from other blood disorders or previous cancer treatment. Those with secondary AML tend to have a less favorable outlook than ...

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...

The approval, according to a notice from the FDA, was based on efficacy data from ... treatment paradigm in patients with ...

The FDA has granted fast track designation to HC-7366 for the treatment of adult patients with relapsed/refractory acute ...

Partow Kebriaei, MD, discusses when the optimal time for transplant is in patients with acute lymphoblastic leukemia.

9, 2024 — Researchers have created a CRISPR-based ... leukemia that are driven by mutations that involve gene fusions. The technology accurately detects the presence of these gene fusions in ...

For children with acute lymphoblastic leukemia (ALL), measurable residual disease (MRD) after the end of first consolidation (EOC) can be used to predict the need for subsequent MRD measurements ...

Oct 21 (Reuters) - Former Hollywood producer Harvey Weinstein has chronic myeloid leukemia (CML), NBC News ... on rape charges in February 2020 in a case that provided impetus for the #MeToo ...

Single-cell analysis of CML patients bone marrow at diagnosis reveals coexistence of CD26-CD35+ healthy stem cells and CD26+CD35- CML stem cells, and how the ratio between these impacts TKI response.

The trial aims to assess Luvelta's efficacy and safety, with most of its sites due to open by the end of the year.